Berobenatide

製品コード：P1287 純度：99.53%

Berobenatide(PF-08653944,MET-097i) is an ultra-long-acting, fully biased GLP-1R agonist that functionally favors Gs/cAMP signaling over β-arrestin recruitment. It induces weight loss in diet-induced obese mice and exhibits the potential to be used in obesity-related research and treatment.

Amino-acid Sequence

PF-08653944,MET-097i

CAS No. 3028974-74-2

当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

製品安全説明書

現在のバッチを見る： P128701 DMSO] 100 mg/mL] false] Water] 100 mg/mL] false] Ethanol] 100 mg/mL] false 純度： 99.53%

99.53

化学情報

保管	3 years-20°C(in the dark) powder	溶液の保管冷凍と解凍の繰り返しを避けるため小分けにしてください	1年-80°Cin solvent
			１ケ月-20°Cin solvent

In vitro
Batch:

DMSO : 100 mg/mL ( ；吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Water : 100 mg/mL

Ethanol : 100 mg/mL

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

生物活性

製品説明	Berobenatide(PF-08653944,MET-097i) is an ultra-long-acting, fully biased GLP-1R agonist that functionally favors Gs/cAMP signaling over β-arrestin recruitment. It induces weight loss in diet-induced obese mice and exhibits the potential to be used in obesity-related research and treatment.

参考
https://pubmed.ncbi.nlm.nih.gov/42515728/ https://diabetesjournals.org/diabetes/article/74/Supplement_1/794-P/158961/794-P-MET-097-Preclinical-Characterization-of-a

参考

https://pubmed.ncbi.nlm.nih.gov/42515728/
https://diabetesjournals.org/diabetes/article/74/Supplement_1/794-P/158961/794-P-MET-097-Preclinical-Characterization-of-a

製品情報

Molecular Formula	C₂₃₂H₃₆₉N₅₇O₆₈
CAS No.	3028974-74-2
Storage (From the date of receipt)	3 years-20°C(in the dark) powder
Shipping	Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)